Sandbox Reserved 1074

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 39: Line 39:
== '''Catalytic Triad''' ==
== '''Catalytic Triad''' ==
-
Structural studies have shown that InhA possesses the <scene name='69/694241/Catalytic_triad/1'> Phe-Tyr-Lys catalytic triad</scene>, composed of Phe-149, Tyr-158, and Lys-165. This catalytic triad of InhA is analogous to the classic Ser-Tyr-Lys catalytic triad of the SDR (Short-chain Dehydrogenase Reductase) family in terms of position and function within the enzyme. As discussed previously, the likely role of Tyr-158 is to position the fatty acyl substrate within the fatty acyl binding crevice. Second, the side chain of the Lys-165 residue in InhA functions similarly to the catalytic Lys residues in other SDR enzymes by interacting with the 3'-hydroxyl of the nicotinamide ring of NADH to hold this cofactor in place within the fatty acyl binding crevice. Finally, the exact role of the catalytic Phe-149 residue in InhA is unknown. It has been hypothesized to play a role in helping the fatty acyl substrate adopt its desired u-shape prior to binding. However, it is more widely believed that this catalytic residue merely distinguishes InhA as a dehydrogenase.
+
Structural studies have shown that InhA possesses the <scene name='69/694241/Catalytic_triad/2'>Phe-Tyr-Lys catalytic triad</scene>, composed of Phe-149, Tyr-158, and Lys-165. This catalytic triad of InhA is analogous to the classic Ser-Tyr-Lys catalytic triad of the SDR (Short-chain Dehydrogenase Reductase) family in terms of position and function within the enzyme. As discussed previously, the likely role of Tyr-158 is to position the fatty acyl substrate within the fatty acyl binding crevice. Second, the side chain of the Lys-165 residue in InhA functions similarly to the catalytic Lys residues in other SDR enzymes by interacting with the 3'-hydroxyl of the nicotinamide ring of NADH to hold this cofactor in place within the fatty acyl binding crevice. Finally, the exact role of the catalytic Phe-149 residue in InhA is unknown. It has been hypothesized to play a role in helping the fatty acyl substrate adopt its desired u-shape prior to binding. However, it is more widely believed that this catalytic residue merely distinguishes InhA as a dehydrogenase.
== '''Clinical Applications''' ==
== '''Clinical Applications''' ==
-
This is a sample scene created with SAT to <scene name="69/697507/Fatty_acyl_binding_crevice/3">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.
+
 
</StructureSection>
</StructureSection>
== References ==
== References ==
<references/>
<references/>

Revision as of 02:48, 8 April 2015

This Sandbox is Reserved from 02/09/2015, through 05/31/2016 for use in the course "CH462: Biochemistry 2" taught by Geoffrey C. Hoops at the Butler University. This reservation includes Sandbox Reserved 1051 through Sandbox Reserved 1080.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • Click the 3D button (when editing, above the wikitext box) to insert Jmol.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Enoyl-ACP Reductase InhA from Mycobacterium tuberculosis

Enoyl-ACP Reductase InhA Homotetramer

Drag the structure with the mouse to rotate

References

Personal tools